Concepedia

Chengzhi Zhang

CZ

5

Publications

312

Citations

5

H-Index

1995

Active since

Affiliations

Maxygen (United States)(Current)

Chengzhi Zhang is an author at Maxygen (United States) specializing in natural sciences, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1995–2024

5

Publications

5

Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.

Michael Newman, Jennifer C. Rodarte, Khalid Benbatoul et al. · PubMed · 2000 · 191 citations

, , +21

2,4,5-Trisubstituted imidazoles

Chengzhi Zhang, Sepehr Sarshar, Edmund J. Moran et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 61 citations

Paeonol suppresses lipid accumulation in macrophages via upregulation of the ATP-binding cassette transporter A1 and downregulation of the cluster of differentiation 36

Xiuying Li, Yuanda Zhou, Chao Yu et al. · International Journal of Oncology · 2014 · 38 citations · Full text

Studies on the Degradation of Mevinolin and Compactin: A Formal Route to Semisynthetic Analogs

Derrick L. J. Clive, Chengzhi Zhang · The Journal of Organic Chemistry · 1995 · 11 citations

, , +20

Hydrogel-Based Therapy for Age-Related Macular Degeneration: Current Innovations, Impediments, and Future Perspectives

Chengzhi Zhang, Jiale Wang, Hao Wu et al. · Gels · 2024 · 11 citations · Full text

Rows per page

1–5 of 5